Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
This article explains the balance between strong cryptography and practical attack vectors, illustrating why no system is perfectly immune to breaches.
28,220 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
A crypto recovery plea in Nanaimo spiraled into a second scam, with criminals spoofing police branding to pressure a ...
Digital platforms connect buyers and sellers worldwide, yet taxes struggle to keep up. This article explains why dest...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...
In a land of hype cycles and volatile headlines, a strong cash-flow machine can outlast the fiercest cannabis hype. T...
As AI hype accelerates, Clarivate (CLVT) quietly leans on its defensible data assets to reduce debt and position for ...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
The U.S. temporarily eases sanctions on Russian oil loaded on tankers for 30 days, aiming to calm markets amid Middle...
A newly installed Fed chair faces a murky policy path as inflation cools. With a split committee and mixed data, kevi...
A recently launched XRP-focused ETF aims to deliver 3% monthly income by selling XRP call options, blending crypto ex...
Coca-Cola has staged a remarkable rally this year, outpacing the broader market. Yet many investors wonder if this ri...